eLabNext and ABI-LAB Announce Strategic Partnership to Foster Innovation in Life Sciences

July 25, 2024 03:51 AM AEST | By EIN Presswire
 eLabNext and ABI-LAB Announce Strategic Partnership to Foster Innovation in Life Sciences
Image source: EIN Presswire

eLabNext and ABI-LAB have announced a strategic alliance aimed at driving the innovation and growth of life sciences startups in Massachusetts.

CAMBRIDGE, MASSACHUSETTS, UNITED STATES, July 24, 2024 /EINPresswire.com/ -- eLabNext and ABI-LAB Announce Strategic Partnership to Foster Innovation in Life Sciences

eLabNext, a leading provider of digital lab management solutions, and ABI-LAB, a premier life sciences incubator located in Natick, MA, have announced a strategic alliance aimed at driving innovation and supporting the growth of life sciences startups.

Under this pioneering collaboration, eLabNext will provide cutting-edge digital lab management solutions to the ventures and residents of ABI-LAB, empowering them to streamline their workflows and accelerate their R&D.

“We are excited to partner with ABI-LAB to support Massachusetts’ vibrant life sciences community,” said Zareh Zurabyan, Head of eLabNext, Americas. “I am excited to see the innovative biotech community outside of Cambridge continue to grow. We are happy to be part of it. By combining our expertise in digital transformation and prepping labs for data analysis using artificial intelligence (AI) and machine learning (ML), we can empower startups to drive scientific discoveries and achieve their full potential.”

As part of the partnership, ABI-LAB tenants will benefit from:

- Access to Innovative Solutions: Residents will have access to eLabNext’s advanced digital lab management tools, including their electronic lab notebook (ELN), laboratory information management system (LIMS), and sample/inventory management software to optimize research and process development workflows.

- Exclusive Incentives and Discounts: All ABI-LAB residents can access tailored incentives and exclusive discounts on eLabNext products and services.

- Educational and Collaborative Opportunities: Residents will be able to participate in co-hosted events, workshops, and training sessions focused on research digitalization, automation, and AI.

- Visibility and Promotion: Startups will gain exposure through guest contributions on eLabNext's website and social media platforms, along with opportunities for features in case studies and promotional content.

“We are thrilled to partner with eLabNext to provide our residents with access to cutting-edge digital lab management solutions,” exclaims Dan Diggins, Director of Partnerships & Marketing at ABI-LAB. “Our goal is to remove operational obstacles that interfere with innovation. This partnership will enable our residents to optimize workflows, streamline processes, and focus more on their R&D efforts.”

ABI-LAB’s life science campus will grow with the addition of ABI-LAB 3, a 35,000 ft2, state-of-the-art lab facility, in November 2024. ABI-LAB is currently home to 45 resident companies, each operating its own private lab space within their two incubator buildings, ABI-LAB 1 and ABI-LAB 2. Residents of ABI-LAB receive access to an array of amenities as part of their tenancy, including advanced instruments in ABI-LAB’s Innovation Lab, routine equipment such as freezers, incubators, and biosafety cabinets, IBC permitting, and access to a portfolio of partner resources and benefits.

Editorial Note

About eLabNext
eLabNext is the most comprehensive Digital Lab Platform (DLP) designed to cater to life science lab operations in academia and industry. From R&D to analytics and diagnostics, the platform enhances workflows with features like electronic lab notebooks (ELN) and laboratory information management systems (LIMS) for sample, inventory, and equipment management. eLabNext is built on a truly open ecosystem featuring a marketplace with a wide range of add-ons to expand digital capabilities. Further enriched by advanced, future-proofed data science capabilities, eLabNext redefines the modern laboratory experience.

For more information about eLabNext, please visit www.elabnext.com.

Press contact:
Name: Zareh Zurabyan
Head of eLabNext, Americas, an Eppendorf Group Company
Email: [email protected]
Website: www.elabnext.com

About ABI-LAB:
ABI-LAB is a life science campus comprised of multiple incubator buildings for biotech companies of all sizes. Their state-of-the-art facilities are designed to support startups and small companies with move-in ready, private lab space, ranging from 500 ft2 to 1,000 ft2. ABI’s modular design and flexible terms allow growing and established companies to configure space ranging anywhere from 1,000 ft2 to 8,000 ft2. In November of 2024, ABI-LAB will open their next incubator building, adding 35,000 ft2 to their existing 105,000 ft2.

For more information about ABI-LAB, please visit https://abi-lab.com/

Press contact:
Name: Dan Diggins
Director, Partnerships & Marketing
Email: [email protected]
Website: https://abi-lab.com/

Zareh Zurabyan
eLabNext
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.